Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells

Objective: Currently, sorafenib is the main systemic chemotherapy drug for advanced stage of hepatocellular carcinoma (HCC). However, emerging data from some clinical HCC patients indicates that sorafenib alone has only moderate antitumor efficacy, and could not inhibit metastasis and progression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Hongqiao, Yang, Yang, Peng, Fenghui, Liu, Yahui, Fu, Xueqi, Ji, Bai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909811/
https://www.ncbi.nlm.nih.gov/pubmed/31839741
http://dx.doi.org/10.7150/ijms.37427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909811/
https://www.ncbi.nlm.nih.gov/pubmed/31839741
http://dx.doi.org/10.7150/ijms.37427

Ejemplares similares